Full-Time

Global Supplier Onboarding & Vendor Master Manager

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Procurement & Sourcing
Operations & Logistics
Requirements
  • Doctorate degree
  • Or
  • Master’s degree and 3 years of Procure to Pay experience
  • Or
  • Bachelor’s degree and 5 years of Procure to Pay experience
  • Or
  • Associate’s degree and 10 years of Procure to Pay experience
  • Or
  • High school diploma / GED and 12 years of Procure to Pay experience
  • And
  • Previous managerial experience directly managing people and/or experience leading teams, projects, programs or directing the allocation of resources
Responsibilities
  • Manage day to day operations and prioritization of the Supplier On-boarding team to ensure critical issues and escalations are being prioritized appropriately
  • Drive decisions related to Supplier On-boarding and vendor master critical issues
  • Ensure regular oversight and maintenance activities of vendor master data are being conducted on a regular basis
  • Work with the team to continually make updates and improvements to the Supplier On-boarding playbook in accordance with the other Service Owners and Process Owners
  • Monitor performance against service level agreements; ensure service level agreements are met; improve performance against SLAs
  • Monitor the performance of the BPO in relation to supplier on-boarding activities; interact with BPO leadership to make improvements to the service level and support structure
  • Ensure compliance to internal and external policies, regulations and laws applicable to the function
  • Manage special projects related to the Supplier On-boarding process and ensure project milestones are being prioritized appropriately
Desired Qualifications
  • Bachelor’s degree in business or any other highly quantitative team
  • 5+ years’ experience in Procure to Pay processes
  • Demonstrated experience working with different partner groups in a multinational corporation
  • Experience working for a Global corporation
  • Ability to lead global virtual teams in a dynamic environment
  • Strong written, verbal communication and inter-personal skills
  • Intermediate to Advanced level knowledge of office tools e.g. MS Excel/MS Word/MS Office/Smartsheet
  • Be customer focused and have problem solving skills
  • Ability to multi-task and work with short timelines

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's approach involves a strong commitment to research and development, using revenue from its approved medicines to fund new treatment discoveries. Unlike many competitors, Amgen emphasizes a robust pipeline of potential therapies at various development stages, aiming to improve patient care and outcomes in the healthcare sector.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.